Wells Fargo Maintains Overweight on Progyny, Raises Price Target to $38

Benzinga · 2d ago
Wells Fargo analyst Stan Berenshteyn maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the price target from $37 to $38.